[The influence of Chlamydia pneumoniae infection on acute coronary syndromes].
Chlamydia pneumoniae is one of the infectious factors the role of which is considered in the process of atherosclerosis and its complications.


OBJECTIVE
Of the study was to assess the incidence of Ch. pneumoniae infection in the patients with acute coronary events. The study was carried out in 36 patients, mean age 61.2 +/- 13.4 years, 27 men and 9 women hospitalised in our Department with the diagnosis of previous or recent acute myocardial infarction. The control group consisted of 19 subjects, aged 61.1 +/- 14.3 years, 10 men and 9 women hospitalised due to other reasons. In all studied patients during the first 24 hours venous blood was taken for the assessment of fibrinogen and C-reactive protein (CRP) concentrations and titres of IgA and IgG anti-Ch. pneumoniae antibodies, and pharyngeal swabs were done for Ch. pneumoniae assessment.


RESULTS
Positive swab tests were found in 19% of the patients, positive IgG titres in 80% and IgA in 64% of the patients. In the control group the corresponding values were 11, 79, 42%, respectively. In the patients with positive IgG titres, negative IgA titre result was observed in 21% and in the control group in 53% (p < 0.05). The CRP level was significantly higher in the studied patients than in the control group (24.2 vs 4.2 mg/l; p < 0.05).


CONCLUSIONS
1. The high percentage of positive serologic tests and rare positive results of pharyngeal swabs indicate a frequent contact with Ch. pneumoniae in human population. 2. Ch. pneumoniae infection exerts no significant influence on the unspecific markers of inflammation. 3. The higher frequency of seroconversion-positive IgG and negative IgA titres--in the control group indicates the role of prolonged or acute Ch. pneumoniae infection in the development or progression of coronary atherosclerosis and its complications.
Katedra i Klinika Kardiologii Akademii Medycznej we Wrocławiu. jgajek@dilnet.wroc.pl
Jacek
J
Gajek
Irena
I
Choroszy-Król
Dorota
D
Zyśko
Dorota
D
Teryks-Wołyniec
Bogumił
B
Halawa
D000208:Acute Disease; D002690:Chlamydia Infections / Q000276:immunology / Q000382:microbiology*; D016993:Chlamydophila pneumoniae / Q000302:isolation & purification*; D003327:Coronary Disease / Q000453:epidemiology* / Q000276:immunology / Q000382:microbiology*; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D015994:Incidence; D008297:Male; D008875:Middle Aged; D015995:Prevalence
D007070:Immunoglobulin A; D007074:Immunoglobulin G